Insider · CIK 0001653224

Gutry Phil

Reports to the SEC for 2 companies · BALTIMORE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001653224

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-04-11	LENZLENZ Therapeutics, Inc.P Purchase	CHIEF BUSINESS OFFICER	PPurchase	+5,000 sh	$4.01	+$20.1K	299,941
2022-02-16	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+115K sh	—	—	115,000
2021-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,718 sh	—	—	4,718
2021-06-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,142 sh	—	—	3,142
2021-06-29	LENZLENZ Therapeutics, Inc. · Series B Preferred StockC Conversion	CHIEF BUSINESS OFFICER	CConversion	−19.8K sh	—	—	0
2021-06-29	LENZLENZ Therapeutics, Inc.C Conversion	CHIEF BUSINESS OFFICER	CConversion	+8,126 sh	—	—	293,471
2021-06-15	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-04-18	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−3,383 sh	—	—	159,027
2021-04-18	LENZLENZ Therapeutics, Inc.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+3,383 sh	$6.11	+$20.7K	285,345
2021-03-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,783 sh	—	—	3,783
2021-03-17	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+69.6K sh	—	—	69,604
2021-03-17	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+162K sh	—	—	162,410
2021-03-11	LENZLENZ Therapeutics, Inc. · Series B Preferred StockA Award	CHIEF BUSINESS OFFICER	AAward	+19.8K sh	$5.06	+$100K	19,763
2021-01-15	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−91.4K sh	—	—	0
2021-01-15	LENZLENZ Therapeutics, Inc.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+91.4K sh	$0.30	+$27.4K	281,962
2021-01-13	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+91.4K sh	—	—	91,406
2020-12-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,877 sh	—	—	3,877
2020-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,516 sh	—	—	4,516
2020-06-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,812 sh	—	—	3,812
2020-06-18	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-03-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,310 sh	—	—	4,310
2019-12-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,375 sh	—	—	2,375
2019-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,907 sh	—	—	3,907
2019-08-07	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-06-28	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,323 sh	—	—	2,323
2019-03-29	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+1,916 sh	—	—	1,916
2018-12-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,439 sh	—	—	3,439
2018-09-28	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+2,351 sh	—	—	2,351
2018-06-29	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+2,544 sh	—	—	2,544
2018-05-15	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,357 sh	—	—	8,357
2018-03-31	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+2,350 sh	—	—	2,350
2017-12-31	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,179 sh	—	—	3,179
2017-09-30	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+10.6K sh	—	—	10,600
2017-06-30	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,224
2017-06-30	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+8,357 sh	—	—	8,357
2017-03-31	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+10.1K sh	—	—	10,131
2016-12-31	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,793 sh	—	—	3,793
2016-09-30	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+886 sh	—	—	886
2016-06-30	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+1,638 sh	—	—	1,638
2016-05-18	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+8,357 sh	—	—	8,357
2015-11-09	AVTXAvalo Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,714

Recent filings

Accepted (ET)
Apr 134
Gutry Phil0001209191-22-024362
SEC(opens sec.gov)
Feb 184
Gutry Phil0001209191-22-011465
SEC(opens sec.gov)
Oct 44
Gutry Phil0001878894-21-000011
SEC(opens sec.gov)
Jul 24
Gutry Phil0001192482-21-000600
SEC(opens sec.gov)
Jul 14
Gutry Phil0000899243-21-027016
SEC(opens sec.gov)
Jun 174
Gutry Phil0001192482-21-000524
SEC(opens sec.gov)
Apr 24
Gutry Phil0001653224-21-000001
SEC(opens sec.gov)
Jan 54
Gutry Phil0001192482-21-000032
SEC(opens sec.gov)
Oct 14
Gutry Phil0001192482-20-000759
SEC(opens sec.gov)
Jul 14
Gutry Phil0001192482-20-000595
SEC(opens sec.gov)
Jun 194
Gutry Phil0001192482-20-000544
SEC(opens sec.gov)

Companies

Address

400 E. PRATT STREET, SUITE 606

BALTIMORE, MD, 21202